Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Neuropharmacology. 2012 Jan 25;62(7):2192–2201. doi: 10.1016/j.neuropharm.2012.01.013

Figure. 2. METH is associated with nonsignificant reductions in lever pressing that is reversed by rimonabant pretreatment.

Figure. 2

Ratio of total bar presses two days before and after drug administration (Mean ±SEM, *p<0.05, One-Way ANOVA, Bonferroni post hoc test.).